4//SEC Filing
SCHLEIFER LEONARD S 4
Accession 0001883850-24-000029
CIK 0000872589other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 4:03 PM ET
Size
7.2 KB
Accession
0001883850-24-000029
Insider Transaction Report
Form 4
SCHLEIFER LEONARD S
DirectorCEO and President10% Owner
Transactions
- Sale
Common Stock
2024-06-06$1015.02/sh−787$798,821→ 64,198 total(indirect: By Trust)
Holdings
- 5,932(indirect: By 401(k))
Common Stock
- 466,877
Common Stock
- 157,552(indirect: 2023 GRAT)
Common Stock
Footnotes (2)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 5, 2024.
- [F2]Represents volume-weighted average price of sales of 787 shares of Company stock on June 6, 2024 at prices ranging from $1,015.00 to $1,015.25. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 6, 2024 at each separate price.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001218629
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 4:03 PM ET
- Size
- 7.2 KB